Percutaneous treatment of valvular heart disease: Die another day.
作者信息
de Winter R J
机构信息
Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
出版信息
Neth Heart J. 2017 Nov;25(11):609-610. doi: 10.1007/s12471-017-1044-6.
Abstract
摘要
相似文献
1
Percutaneous treatment of valvular heart disease: Die another day.经皮治疗心脏瓣膜病：来日无多。
Neth Heart J. 2017 Nov;25(11):609-610. doi: 10.1007/s12471-017-1044-6.
2
Characteristics, aetiological spectrum and management of valvular heart disease in a Tunisian cardiovascular centre.突尼斯某心血管中心瓣膜性心脏病的特征、病因谱及管理
Arch Cardiovasc Dis. 2017 Aug-Sep;110(8-9):439-446. doi: 10.1016/j.acvd.2016.08.003. Epub 2017 Jan 20.
3
The evolving role of cardiac imaging in percutaneous valvular intervention.心脏影像学在经皮瓣膜介入治疗中的不断演变的作用。
Heart Lung Circ. 2013 Sep;22(9):704-16. doi: 10.1016/j.hlc.2013.03.080. Epub 2013 May 28.
4
Advances in percutaneous valvular intervention.经皮瓣膜介入治疗的进展
Expert Rev Cardiovasc Ther. 2005 Jan;3(1):143-58. doi: 10.1586/14779072.3.1.143.
5
State of the art percutaneous intervention for the treatment of valvular heart disease: a review of the current technologies and ongoing research in the field of percutaneous valve replacement and repair.治疗心脏瓣膜病的先进经皮介入技术：经皮瓣膜置换与修复领域的当前技术及正在进行的研究综述
Cardiology. 2007;107(2):87-96. doi: 10.1159/000094387. Epub 2006 Jul 6.
6
[Percutaneous approaches in valvular heart diseases].[经皮介入治疗瓣膜性心脏病]
Anadolu Kardiyol Derg. 2009 Jul;9 Suppl 1:50-8.
7
Advances in percutaneous treatment for adult valvular heart disease.经皮治疗成人心脏瓣膜病的进展。
Intern Med J. 2009 Jul;39(7):465-74. doi: 10.1111/j.1445-5994.2008.01877.x.
8
Valvular heart disease: diagnosis and management.心脏瓣膜病：诊断与管理
J Assoc Physicians India. 2007 Aug;55:575-84.
9
Treatment of valvular heart disease during pregnancy for improving maternal and neonatal outcome.孕期瓣膜性心脏病的治疗以改善母婴结局。
Cochrane Database Syst Rev. 2011 May 11(5):CD008128. doi: 10.1002/14651858.CD008128.pub2.
10
The inoperable valvular heart disease patient:the pluses and minuses of percutaneous valvular replacement.无法进行手术的心脏瓣膜病患者：经皮瓣膜置换术的利弊
EuroIntervention. 2006 Aug;2(2):154-60.
本文引用的文献
1
Mitro-aortic pathology: a point of view for a fully transcatheter staged approach.二尖瓣-主动脉病变：全经导管分期治疗方法的观点
Neth Heart J. 2017 Nov;25(11):605-608. doi: 10.1007/s12471-017-1028-6. Epub 2017 Aug 2.
2
The preoperative cardiology consultation: indications and risk modification.术前心脏科会诊：适应证与风险修正
Neth Heart J. 2017 Nov;25(11):629-633. doi: 10.1007/s12471-017-1004-1.
3
The Rationale for Performance of Coronary Angiography and Stenting Before Transcatheter Aortic Valve Replacement: From the Interventional Section Leadership Council of the American College of Cardiology.经导管主动脉瓣置换术前行冠状动脉造影和支架置入术的理由：来自美国心脏病学会介入治疗分会领导层理事会。
JACC Cardiovasc Interv. 2016 Dec 12;9(23):2371-2375. doi: 10.1016/j.jcin.2016.09.024.
4
2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.2014年美国心脏病学会/美国心脏协会非心脏手术患者围手术期心血管评估和管理指南：美国心脏病学会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2014 Dec 9;64(22):e77-137. doi: 10.1016/j.jacc.2014.07.944. Epub 2014 Aug 1.
Zotero 插件